Advertisement

Annals of Hematology

, Volume 97, Issue 9, pp 1745–1745 | Cite as

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study

  • Alexander Egle
  • Michael Steurer
  • Thomas Melchardt
  • Lukas Weiss
  • Franz Josef Gassner
  • Nadja Zaborsky
  • Roland Geisberger
  • Kemal Catakovic
  • Tanja Nicole Hartmann
  • Lisa Pleyer
  • Daniela Voskova
  • Josef Thaler
  • Alois Lang
  • Michael Girschikofsky
  • Andreas Petzer
  • Richard Greil
Correction
  • 284 Downloads

Correction to: Annals of Hematology

  https://doi.org/10.1007/s00277-018-3380-z

The original version of this article contained a mistake. The name of Tanja Nicole Hartman should have been Tanja Nicole Hartmann.

The original article has been corrected.

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Alexander Egle
    • 1
    • 2
  • Michael Steurer
    • 3
  • Thomas Melchardt
    • 1
    • 2
  • Lukas Weiss
    • 1
    • 2
  • Franz Josef Gassner
    • 2
  • Nadja Zaborsky
    • 2
  • Roland Geisberger
    • 2
  • Kemal Catakovic
    • 2
  • Tanja Nicole Hartmann
    • 2
  • Lisa Pleyer
    • 1
    • 2
  • Daniela Voskova
    • 4
  • Josef Thaler
    • 5
  • Alois Lang
    • 6
  • Michael Girschikofsky
    • 7
  • Andreas Petzer
    • 8
  • Richard Greil
    • 1
    • 2
  1. 1.Department of Internal Medicine III with Hematology and Medical Oncology, Oncologic CenterParacelsus Medical University SalzburgSalzburgAustria
  2. 2.Salzburg Cancer Research Institute - Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR) and Cancer Cluster Salzburg (CCS)SalzburgAustria
  3. 3.Division of Hematology and Oncology, Laboratory for Molecular Genetics and DiagnosticsInnsbruck Medical UniversityInnsbruckAustria
  4. 4.Centre for Hematology and Medical OncologyKepler University HospitalLinzAustria
  5. 5.Department for Internal Medicine IVHospital Wels-GrieskirchenWelsAustria
  6. 6.Internal Medicine, HospitalFeldkirchAustria
  7. 7.Internal Medicine I (Hemostasis, Hematology and Stem Cell Transplantation and Medical Oncology)Ordensklinikum Linz ElisabethinenLinzAustria
  8. 8.Department for Internal Medicine IVHospital Barmherzige Schwestern LinzLinzAustria

Personalised recommendations